{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:49Z","timestamp":1772165629971,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Osaka Foundation for the Prevention of Cancer and Lifestyle-related Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04108-2","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T04:16:33Z","timestamp":1752898593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of neoadjuvant chemoradiation therapy in resectable pancreatic cancer was independent of intratumoral vascularization"],"prefix":"10.1186","volume":"25","author":[{"given":"Tomomi","family":"Yasue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiko","family":"Ashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Takada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ikezawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigenori","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruki","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Akita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Doki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetoshi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"issue":"1","key":"4108_CR1","first-page":"7","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4108_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1136\/gut.2010.226092","volume":"60","author":"A Neesse","year":"2011","unstructured":"Neesse A, Michl P, Frese KK, Feig C, Cook N, Jacobetz MA, Lolkema MP, Buchholz M, Olive KP, Gress TM, et al. Stromal biology and therapy in pancreatic cancer. Gut. 2011;60(6):861\u20138.","journal-title":"Gut"},{"issue":"3","key":"4108_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ccr.2012.01.007","volume":"21","author":"PP Provenzano","year":"2012","unstructured":"Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(3):418\u201329.","journal-title":"Cancer Cell"},{"issue":"5933","key":"4108_CR4","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1126\/science.1171362","volume":"324","author":"KP Olive","year":"2009","unstructured":"Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Sci (New York NY). 2009;324(5933):1457\u201361.","journal-title":"Sci (New York NY)"},{"issue":"2","key":"4108_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00261-008-9460-0","volume":"35","author":"H Hata","year":"2010","unstructured":"Hata H, Mori H, Matsumoto S, Yamada Y, Kiyosue H, Tanoue S, Hongo N, Kashima K. Fibrous stroma and vascularity of pancreatic carcinoma: correlation with enhancement patterns on CT. Abdom Imaging. 2010;35(2):172\u201380.","journal-title":"Abdom Imaging"},{"issue":"Suppl 1","key":"4108_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/den.12454","volume":"27","author":"M Kitano","year":"2015","unstructured":"Kitano M, Kamata K, Imai H, Miyata T, Yasukawa S, Yanagisawa A, Kudo M. Contrast-enhanced harmonic endoscopic ultrasonography for pancreatobiliary diseases. Dig Endoscopy: Official J Japan Gastroenterological Endoscopy Soc. 2015;27(Suppl 1):60\u20137.","journal-title":"Dig Endoscopy: Official J Japan Gastroenterological Endoscopy Soc"},{"issue":"6","key":"4108_CR7","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3109\/00365521003690269","volume":"45","author":"H Imazu","year":"2010","unstructured":"Imazu H, Uchiyama Y, Matsunaga K, Ikeda K, Kakutani H, Sasaki Y, Sumiyama K, Ang TL, Omar S, Tajiri H. Contrast-enhanced harmonic EUS with novel ultrasonographic contrast (Sonazoid) in the preoperative T-staging for pancreaticobiliary malignancies. Scand J Gastroenterol. 2010;45(6):732\u20138.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"4108_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1055\/s-0030-1255537","volume":"42","author":"B Napoleon","year":"2010","unstructured":"Napoleon B, Alvarez-Sanchez MV, Gincoul R, Pujol B, Lefort C, Lepilliez V, Labadie M, Souquet JC, Queneau PE, Scoazec JY, et al. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study. Endoscopy. 2010;42(7):564\u201370.","journal-title":"Endoscopy"},{"issue":"7","key":"4108_CR9","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cgh.2010.04.012","volume":"8","author":"P Fusaroli","year":"2010","unstructured":"Fusaroli P, Spada A, Mancino MG, Caletti G. Contrast harmonic echo-endoscopic ultrasound improves accuracy in diagnosis of solid pancreatic masses. Clin Gastroenterol Hepatol. 2010;8(7):629-634.e621-622.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"4108_CR10","doi-asserted-by":"publisher","first-page":"E369","DOI":"10.1055\/a-1782-5033","volume":"10","author":"Y Yamashita","year":"2022","unstructured":"Yamashita Y, Shimokawa T, Ashida R, Napol\u00e9on B, Lisotti A, Fusaroli P, Gincul R, Dietrich CF, Omoto S, Kitano M. Comparison of endoscopic ultrasonography with and without contrast enhancement for characterization of pancreatic tumors: a meta-analysis. Endoscopy Int Open. 2022;10(4):E369\u201377.","journal-title":"Endoscopy Int Open"},{"issue":"2","key":"4108_CR11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.giec.2012.04.013","volume":"22","author":"M Kitano","year":"2012","unstructured":"Kitano M, Sakamoto H, Kudo M. Endoscopic ultrasound: contrast enhancement. Gastrointest Endosc Clin N Am. 2012;22(2):349\u201358.","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"Suppl 1","key":"4108_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/den.12179","volume":"26","author":"M Kitano","year":"2014","unstructured":"Kitano M, Sakamoto H, Kudo M. Contrast-enhanced endoscopic ultrasound. Dig Endoscopy: Official J Japan Gastroenterological Endoscopy Soc. 2014;26(Suppl 1):79\u201385.","journal-title":"Dig Endoscopy: Official J Japan Gastroenterological Endoscopy Soc"},{"issue":"6","key":"4108_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00535-005-1598-8","volume":"40","author":"K Numata","year":"2005","unstructured":"Numata K, Ozawa Y, Kobayashi N, Kubota T, Shimada H, Nozawa A, Nakatani Y, Sugimori K, Matsuo K, Imada T, et al. Contrast-enhanced sonography of pancreatic carcinoma: correlations with pathological findings. J Gastroenterol. 2005;40(6):631\u201340.","journal-title":"J Gastroenterol"},{"issue":"4","key":"4108_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.ultrasmedbio.2015.12.008","volume":"42","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yan K, Fan Z, Sun L, Wu W, Yang W. Contrast-Enhanced ultrasonography of pancreatic carcinoma: correlation with pathologic findings. Ultrasound Med Biol. 2016;42(4):891\u20138.","journal-title":"Ultrasound Med Biol"},{"issue":"6","key":"4108_CR15","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1097\/MPA.0b013e31827fe94c","volume":"42","author":"Y Yamashita","year":"2013","unstructured":"Yamashita Y, Ueda K, Itonaga M, Yoshida T, Maeda H, Maekita T, Iguchi M, Tamai H, Ichinose M, Kato J. Tumor vessel depiction with contrast-enhanced endoscopic ultrasonography predicts efficacy of chemotherapy in pancreatic cancer. Pancreas. 2013;42(6):990\u20135.","journal-title":"Pancreas"},{"key":"4108_CR16","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.2147\/CMAR.S307079","volume":"13","author":"T Zhou","year":"2021","unstructured":"Zhou T, Tan L, Gui Y, Zhang J, Chen X, Dai M, Xiao M, Zhang Q, Chang X, Xu Q, et al. Correlation between enhancement patterns on transabdominal ultrasound and survival for pancreatic ductal adenocarcinoma. Cancer Manage Res. 2021;13:6823\u201332.","journal-title":"Cancer Manage Res"},{"issue":"4","key":"4108_CR17","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.pan.2022.04.005","volume":"22","author":"T Emori","year":"2022","unstructured":"Emori T, Ashida R, Tamura T, Kawaji Y, Hatamaru K, Itonaga M, Yamashita Y, Shimokawa T, Higashino N, Ikoma A, et al. Contrast-enhanced harmonic endoscopic ultrasonography for predicting the efficacy of first-line gemcitabine and nab-paclitaxel chemotherapy in pancreatic cancer. Pancreatology: Official J Int Association Pancreatology (IAP) [et al]. 2022;22(4):525\u201333.","journal-title":"Pancreatology: Official J Int Association Pancreatology (IAP) [et al]"},{"key":"4108_CR18","doi-asserted-by":"crossref","unstructured":"Burko\u0148 P, Trna J, Sl\u00e1vik M, N\u011bme\u010dek R, Kazda T, Posp\u00ed\u0161il P, Dastych M, Eid M, Novotn\u00fd I, Proch\u00e1zka T, et al. Stereotactic body radiotherapy (SBRT) of pancreatic cancer-a critical review and practical consideration. Biomed. 2022;10(10):2480.","DOI":"10.3390\/biomedicines10102480"},{"issue":"1","key":"4108_CR19","doi-asserted-by":"publisher","first-page":"31348","DOI":"10.1038\/s41598-024-82757-1","volume":"14","author":"T Samuel","year":"2024","unstructured":"Samuel T, Rapic S, Lindsay PE, DaCosta RS. Investigating the effects of stereotactic body radiation therapy on pancreatic tumor hypoxia and microvasculature in an orthotopic mouse model using intravital fluorescence microscopy. Sci Rep. 2024;14(1):31348.","journal-title":"Sci Rep"},{"issue":"6","key":"4108_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/SLA.0b013e31829b3ce4","volume":"258","author":"H Takahashi","year":"2013","unstructured":"Takahashi H, Ohigashi H, Gotoh K, Marubashi S, Yamada T, Murata M, Ioka T, Uehara H, Yano M, Ishikawa O. Preoperative gemcitabine-based chemoradiation therapy for resectable and borderline resectable pancreatic cancer. Ann Surg. 2013;258(6):1040\u201350.","journal-title":"Ann Surg"},{"issue":"6","key":"4108_CR21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1097\/SLA.0000000000001547","volume":"264","author":"H Takahashi","year":"2016","unstructured":"Takahashi H, Akita H, Tomokuni A, Kobayashi S, Ohigashi H, Fijiwara Y, Yano M, Sakon M, Ishikawa O. Preoperative Gemcitabine-based chemoradiation therapy for borderline resectable pancreatic cancer: impact of venous and arterial involvement status on surgical outcome and pattern of recurrence. Ann Surg. 2016;264(6):1091\u20137.","journal-title":"Ann Surg"},{"issue":"4","key":"4108_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.giec.2017.06.002","volume":"27","author":"M Kitano","year":"2017","unstructured":"Kitano M, Yamashita Y. New imaging techniques for endoscopic ultrasonography: Contrast-Enhanced endoscopic ultrasonography. Gastrointest Endosc Clin N Am. 2017;27(4):569\u201383.","journal-title":"Gastrointest Endosc Clin N Am"},{"issue":"1","key":"4108_CR23","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159\u201374.","journal-title":"Biometrics"},{"issue":"5","key":"4108_CR24","first-page":"360","volume":"37","author":"AJ Viera","year":"2005","unstructured":"Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med. 2005;37(5):360\u20133.","journal-title":"Fam Med"},{"key":"4108_CR25","volume-title":"TNM Classification of Malignant Tumours","author":"JD Brierley","year":"2017","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours. 8th ed. edn: Wiley-Blackwell; 2017.","edition":"8"},{"issue":"11","key":"4108_CR26","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/archsurg.1992.01420110083017","volume":"127","author":"DB Evans","year":"1992","unstructured":"Evans DB, Rich TA, Byrd DR, Cleary KR, Connelly JH, Levin B, Charnsangavej C, Fenoglio CJ, Ames FC. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Archives Surg (Chicago Ill: 1960). 1992;127(11):1335\u20139.","journal-title":"Archives Surg (Chicago Ill: 1960)"},{"issue":"1","key":"4108_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/SLA.0b013e3181ad65cc","volume":"250","author":"H Ohigashi","year":"2009","unstructured":"Ohigashi H, Ishikawa O, Eguchi H, Takahashi H, Gotoh K, Yamada T, Yano M, Nakaizumi A, Uehara H, Tomita Y, et al. Feasibility and efficacy of combination therapy with preoperative full-dose gemcitabine, concurrent three-dimensional conformal radiation, surgery, and postoperative liver perfusion chemotherapy for T3-pancreatic cancer. Ann Surg. 2009;250(1):88\u201395.","journal-title":"Ann Surg"},{"issue":"13","key":"4108_CR28","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1245\/s10434-019-07735-8","volume":"26","author":"H Eguchi","year":"2019","unstructured":"Eguchi H, Takeda Y, Takahashi H, Nakahira S, Kashiwazaki M, Shimizu J, Sakai D, Isohashi F, Nagano H, Mori M, et al. A prospective, Open-Label, multicenter phase 2 trial of neoadjuvant therapy using Full-Dose gemcitabine and S-1 concurrent with radiation for resectable pancreatic ductal adenocarcinoma. Ann Surg Oncol. 2019;26(13):4498\u2013505.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"4108_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.4103\/2303-9027.187862","volume":"5","author":"A Yamabe","year":"2016","unstructured":"Yamabe A, Irisawa A, Bhutani MS, Shibukawa G, Fujisawa M, Sato A, Yoshida Y, Arakawa N, Ikeda T, Igarashi R, et al. Efforts to improve the diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for pancreatic tumors. Endoscopic Ultrasound. 2016;5(4):225\u201332.","journal-title":"Endoscopic Ultrasound"},{"issue":"1","key":"4108_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/MPA.0b013e318183ff73","volume":"38","author":"K Tawada","year":"2009","unstructured":"Tawada K, Yamaguchi T, Kobayashi A, Ishihara T, Sudo K, Nakamura K, Hara T, Denda T, Matsuyama M, Yokosuka O. Changes in tumor vascularity depicted by contrast-enhanced ultrasonography as a predictor of chemotherapeutic effect in patients with unresectable pancreatic cancer. Pancreas. 2009;38(1):30\u20135.","journal-title":"Pancreas"},{"issue":"2","key":"4108_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ajg.2011.354","volume":"107","author":"M Kitano","year":"2012","unstructured":"Kitano M, Kudo M, Yamao K, Takagi T, Sakamoto H, Komaki T, Kamata K, Imai H, Chiba Y, Okada M, et al. Characterization of small solid tumors in the pancreas: the value of contrast-enhanced harmonic endoscopic ultrasonography. Am J Gastroenterol. 2012;107(2):303\u201310.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"4108_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.prro.2019.06.016","volume":"9","author":"M Palta","year":"2019","unstructured":"Palta M, Godfrey D, Goodman KA, Hoffe S, Dawson LA, Dessert D, Hall WA, Herman JM, Khorana AA, Merchant N, et al. Radiation therapy for pancreatic cancer: executive summary of an ASTRO clinical practice guideline. Practical Radiation Oncol. 2019;9(5):322\u201332.","journal-title":"Practical Radiation Oncol"},{"issue":"10041","key":"4108_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","volume":"388","author":"K Uesaka","year":"2016","unstructured":"Uesaka K, Boku N, Fukutomi A, Okamura Y, Konishi M, Matsumoto I, Kaneoka Y, Shimizu Y, Nakamori S, Sakamoto H, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet (London England). 2016;388(10041):248\u201357.","journal-title":"Lancet (London England)"},{"issue":"6","key":"4108_CR34","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.hpb.2020.01.001","volume":"22","author":"M Ye","year":"2020","unstructured":"Ye M, Zhang Q, Chen Y, Fu Q, Li X, Bai X, Liang T. Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis. HPB: Official J Int Hepato Pancreato Biliary Association. 2020;22(6):821\u201332.","journal-title":"HPB: Official J Int Hepato Pancreato Biliary Association"},{"issue":"11","key":"4108_CR35","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.21.02233","volume":"40","author":"E Versteijne","year":"2022","unstructured":"Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, et al. Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: Long-Term results of the Dutch randomized PREOPANC trial. J Clin Oncology: Official J Am Soc Clin Oncol. 2022;40(11):1220\u201330.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"8","key":"4108_CR36","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.pan.2023.10.016","volume":"23","author":"Y Yamashita","year":"2023","unstructured":"Yamashita Y, Ashida R, Kojima F, Okada KI, Kawai M, Yamazaki H, Tamura T, Kawaji Y, Tamura T, Hatamaru K, et al. Utility of contrast-enhanced harmonic endoscopic ultrasonography for prediction of pathological response after neoadjuvant chemotherapy in patients with pancreatic cancer. Pancreatology. 2023;23(8):1014\u20139.","journal-title":"Pancreatology"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04108-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04108-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:45:45Z","timestamp":1757256345000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04108-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4108"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04108-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5140786\/v1","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol of this study was approved by the Osaka International Cancer Institute, Institutional Review Board (IRB No. 20134). It strictly followed the Declaration of Helsinki and other relevant guidelines. All the patients signed written informed consent to use their clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"526"}}